Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05033223
Other study ID # 69HCL21_0311
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 12, 2021
Est. completion date January 16, 2022

Study information

Verified date January 2022
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The COVID-19 outbreak has been categorized as a pandemic and declared an international public health emergency by WHO. In this context, an exceptional mobilization and a complete reorganization of the organization of the healthcare offer was put in place.The investigators will study the psychological consequences among emergency department (ED) / SAMU (Service d'Aide Médicale Urgente) professionals exposed during the COVID-19 pandemic to high psychological stress due to work overload, changes in practices and fears of contamination.They will evaluate at 9 and 12 months after the end of the second lockdown (July December 2020), post-traumatic stress disorder (PTSD), personal and professional stress, anxiety and depression, burn-out and consumption of anxiolytic products. This is a multi-center study and includes doctors, DE interns and nurses, other paramedics and medical regulatory assistants working in one of the ED or SAMU working during phase 3 of the COVID-19 pandemic. It should make it possible to know the psychological load of the months following the epidemic among health professionals who worked in emergencies during this period and to understand their risk of occurrence of PTSD. These elements are also essential to improve the management of health crises and to put in place preventive measures for health professionals, in particular in anticipation of recurrences, second wave or future new episode.


Recruitment information / eligibility

Status Completed
Enrollment 71
Est. completion date January 16, 2022
Est. primary completion date January 16, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults - Administrative and technical medical staff of the Hospices Civils de Lyon - Contractual or holder - Having participated in the COVER PRO study - Working in one of the HCL phase 3 departments of the COVID-19 pandemic. - Affiliated with a social security system - Having signed an informed consent Exclusion Criteria: - Refusal to participate - Major under legal protection

Study Design


Intervention

Other:
PTSD evaluation of emergency room staff 9 and 12 months after the end of second lockdown in France during COvid-19 pandemic
PCL-5 autoquestionnaire to make the PTSD diagnosis

Locations

Country Name City State
France Service d'Accueil des Urgences Pierre-Bénite

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Existence of a Post Traumatic Stress Disorder (PTSD) at 12 months using PTSD Scale : Existence of a PTSD after the end of the second lockdown using the PCL-5 scale (Post Traumatic Stress Disorder Checklist, 20 items, self-questionnaire) validated in French for PTSD screening. The presence of a "probable PTSD" will be defined by a cut-off score of 31/80 and at least a positive response to one of the four questions asking if the symptoms were causing difficulties in relations with family, friends, work or in daily life 12 months after the end of the second Lockdown (December 2020)
Secondary Existence of a Post Ttraumatic Stress Disorder (PTSD) 9 months using PTSD Scale Existence of a PTSD after the end of the second lockdown using the PCL-5 scale (Post Traumatic Stress Disorder Checklist, 20 items, self-questionnaire) validated in French for PTSD screening. The presence of a "probable PTSD" will be defined by a cut-off score of 31/80 and at least a positive response to one of the four questions asking if the symptoms were causing difficulties in relations with family, friends, work or in daily life 9months after the end of the second Lockdown (December 2020)
Secondary Anxiety evaluation at 12 months using HAD scale Existence of anxious symptomatology assessed by the HAD scale. 14 items, cut-off score: 8 suspected disorder, 11: proven disorder 12months after the end of the second Lockdown (December 2020)
Secondary Anxiety evaluation at 9 months using HAD scale Existence of anxious symptomatology assessed by the HAD scale. 14 items, cut-off score: 8 suspected disorder, 11: proven disorder 9months after the end of the second Lockdown (December 2020)
Secondary Depression evaluation at 12 months using HAD scale Existence of depression symptomatology assessed by the HAD scale. 14 items, cut-off score: 8 suspected disorder, 11: proven disorder 12months after the end of the second Lockdown (December 2020)
Secondary Depression evaluation at 9 months using HAD scale Existence of depression symptomatology assessed by the HAD scale. 14 items, cut-off score: 8 suspected disorder, 11: proven disorder 9months after the end of the second Lockdown (December 2020)
Secondary Presence of a Burn out at 12 months using the Maslach Burnot Inventory (MBI) scale Burnout characterized by the Maslach burnout inventory scale. All MBI items are scored using a 7 level frequency ratings from "never" to "daily." The MBI has three component scales: emotional exhaustion (9 items), depersonalization (5 items) and personal achievement (8 items). Each scale measures its own unique dimension of burnout. 12months after the end of the second Lockdown (December 2020)
Secondary Presence of a Burn out at 9 months using the MBI scale Burnout characterized by the Maslach burnout inventory scale. All MBI items are scored using a 7 level frequency ratings from "never" to "daily." The MBI has three component scales: emotional exhaustion (9 items), depersonalization (5 items) and personal achievement (8 items). Each scale measures its own unique dimension of burnout. 9months after the end of the second Lockdown (December 2020)
Secondary Work-related stress measured using Karasek questionnaire at 12 months Work-related stress measured using Karasek questionnaire at 12 months 12months after the end of the second Lockdown (December 2020)
Secondary Work-related stress measured using Karasek questionnaire at 9 months Work-related stress measured using Karasek questionnaire at 9 months 9months after the end of the second Lockdown (December 2020)
Secondary Consumption of psychoactive substances at 12 months Change in the consumption of psychoactive substances at 12 months 12months after the end of the second Lockdown (December 2020)
Secondary Percentage of patients with psychological Support at 12 months Percentage of patients who benefit from a psychological support at 12 months 12months after the end of the second Lockdown (December 2020)
Secondary Mean number of days of sick leave at 12 months Mean number of days of sick leave at 12 months 12months after the end of the second Lockdown (December 2020)
See also
  Status Clinical Trial Phase
Recruiting NCT05915013 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response Phase 1
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Recruiting NCT05934162 - Efficacy of Internet-delivered Cognitive-behavior Therapy for PTSD N/A
Recruiting NCT05934175 - Intensive Treatment Versus Standard Weekly Prolonged Exposure for Adults With Post-Traumatic Stress Disorder N/A
Completed NCT04460014 - Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT N/A
Completed NCT05877807 - Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
Active, not recruiting NCT05992649 - The Effect of Aquatic Physiotherapy on Veterans Suffering From PTSD - a 40-week Pilotproject N/A
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Not yet recruiting NCT05331534 - Effect of Attentional Therapy on Post-traumatic Stress Disorder N/A
Not yet recruiting NCT04076215 - Biochemical and Physiological Response to Stressogenic Stimuli N/A
Not yet recruiting NCT03649607 - Accelerated Resolution Therapy for HIV Positive African, Caribbean and Black N/A
Not yet recruiting NCT02545192 - A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments Phase 1
Completed NCT02329418 - Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit N/A
Active, not recruiting NCT00978484 - A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder Phase 3
Completed NCT00760734 - Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD) Phase 1
Completed NCT03278171 - Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit
Recruiting NCT05874362 - People Bereaved by Violent Death : Negative Event Biases and Temporal Perception N/A
Terminated NCT03898843 - Assisted Animal Therapy: ReAnimal N/A
Recruiting NCT04747379 - Psychological Effect of Explicit Recall After Sedation (PEERS)
Completed NCT03248167 - Cannabidiol as a Treatment for AUD Comorbid With PTSD Phase 1/Phase 2